XML 17 R20.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Equity Transactions (Tables)
6 Months Ended
Dec. 31, 2019
Disclosure Stock Options Tables Abstract  
Schedule of Stock Option Issued

The following table summarizes the activity relating to the Company’s stock options for the six months ended December 31, 2019:

 

    Options   Weighted-Average Exercise Price   Weighted Remaining Average Contractual Term   Aggregate Intrinsic Value
Outstanding at June 30, 2019     58,000     $ 12.50       5.2     $ 87,480  
Granted     2,400       7.42       4.1       —    
Options Exercised or Forfeited     —         —         —         —    
Outstanding at December 31, 2019     60,400     $ 12.29       4.5     $ 2,100  
Exercisable at December 31, 2019     60,400     $ 12.29       4.5     $ 2,100  

 

The pricing model reflected the following weighted-average assumptions for the six months ended December 31, 2019:

    December 31 2019   December 31 2018
Expected life of options (In years)     5       5  
Expected volatility     71.55 %     67.91 %
Risk free interest rate     1.61 %     2.98 %
Dividend Yield     0 %     0 %
Schedule of option outstanding and exercisable by exercise price

The following is a summary of stock options outstanding and exercisable by exercise price as of December 31, 2019:

Exercise Price   Outstanding   Weighted Average Contract Life   Exercisable
$ 3.75       5,600       4.1       5,600  
$ 6.25       11,200       4.2       11,200  
$ 7.50       25,600       6.2       25,600  
$ 8.75       1,600       4.3       1,600  
$ 12.50       4,000       3.1       4,000  
$ 25.00       1,600       2.8       1,600  
$ 26.25       4,400       2.3       4,400  
$ 27.50       800       2.2       800  
$ 28.75       1,600       2.6       1,600  
$ 31.25       4,000       1.9       4,000  
Schedule of Warrants Issued

Stock Warrants

The following table summarizes the warrants activity during the six months ended December 31, 2019:

 

    Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Life (Years)   Aggregate Intrinsic Value
Outstanding and exercisable at June 30, 2019     124,667     $ 45.00       5.6     $ 716,653  
Granted     1,250,000     $ 4.00       4.7     $ —    
Expired     —       $ —         —       $ —    
Outstanding and exercisable at December 31, 2019     1,374,667     $ 7.72       4.7     $ 139,498